Table 2. Demographics and characteristics data of migraineurs by class of anti-migraine drugs.
| NSAIDs | Combination analgesics | Triptans | Triptans + NSAIDs | Prophylaxis drugs | P-value | |
|---|---|---|---|---|---|---|
| Migraineurs [N (%)] | ||||||
| Low Frequency | 263 (16.5) | 235 (14.8) | 38 (2.3) | 22 (1.3) | 92 (5.8) | 0.015 |
| High frequency | 109 (6.8) | 77 (4.8) | 106 (6.6) | 127 (8.0) | 60 (3.7) | |
| Chronic | 43 (2.7) | 68 (4.2) | 127 (8.0) | 194 (12.2) | 36 (2.2) | |
| Total | 415 (26.1) | 380 (23.9) | 271 (17.0) | 343 (21.6) | 188 (11.8) | |
| Median age [yrs (±IQR**)] | 26 (8–34) | 27 (8–38) | 29 (11–43) | 30 (10–54) | 33 (12–47) | 0.035 |
| Gender (%) M/F | 46.1/53.9 | 53.7/46.3 | 38.7/61.3 | 34.4/64.6 | 53.3/46.5 | 0.038 |
| Patients with depression [N (%)] | 40 (2.5) | 49 (3.0) | 29 (1.8) | 42 (2.6) | 129 (8.1) | 0.007 |
| Epilepticus seizures [N (%)] | 28 (1.7) | 41 (2.5) | 22 (1.3) | 19 (1.1) | 234 (14.7) | 0.002 |
| Patients with other comorbidities [N (%)] | 54 (3.4) | 24 (1.5) | 39 (2.4) | 20 (1.2) | 152 (9.5) | 0.032 |
*Total (1597 N) Patients
**Interquartile range